Marco Carretta
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
MLL-AF9 expression levels do not instruct lineage fate.
Journal: Haematologica
Published: December 10, 2025
Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells.
Journal: Frontiers in immunology
Published: October 12, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2023
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.
Journal: Oncoimmunology
Published: February 03, 2022
Uncovering mediators of collagen degradation in the tumor microenvironment.
Journal: Matrix biology plus
Published: November 26, 2021
Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment.
Journal: Oncogene
Published: July 07, 2021
Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
Journal: Cancer immunology research
Published: April 19, 2021
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Journal: Oncoimmunology
Published: September 14, 2020
Loss of Ambra1 promotes melanoma growth and invasion.
Journal: Nature communications
Published: July 22, 2020
Collagen Density Modulates the Immunosuppressive Functions of Macrophages.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 10, 2019
Collagen density regulates the activity of tumor-infiltrating T cells.
Journal: Journal for immunotherapy of cancer
Published: November 01, 2018
Last Updated: 09/26/2026